Abstract
Cowden syndrome (CS) is an autosomal dominant genodermatosis and represents one of the clinical disorders on the spectrum linked to the germline mutation in the phosphatase and tensin homolog gene (PTEN). Located on chromosome 10, the PTEN gene is a dual specificity phosphatase which plays various roles in cell migration, apoptosis, and all processes that are important in the regulation of normal cellular growth [1]. Mutations in PTEN have been associated with various other disorders including Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, adult L’hermitte-Duclos disease, and autism-like disorders associated with macrocephaly [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tamguney T, Stokoe D. New insights into PTEN. J Cell Sci. 2007;120(23):4071–9.
Pilarski R. Cowden syndrome: a critical review of the literature. J Genet Counsel. 2009;18:13–27.
Lloyd KM, Denis M. Cowden disease: a possible new symptom complex with multiple symptom involvement. Ann Inten Med. 1963;58:136–42.
Weary PE, Gorlin RJ, Gentry WC, Comer JE, Greer KE. Multiple hematoma syndrome (Cowden disease). Arch Dermatol. 1972;106(5):682–90.
Nelen MR, Kremer H, Konigns IBM, Schoute F, van Essen AJ, Koch R, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype phenotype correlations. Eur J Human Genet. 1999;7:267–73.
Starlink T, Cander Veen J, Artwert F, Erikson AW. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 1986;29:222–33.
Salem OS, Steck WD. Cowden’s disease. A case report and review of the English literature. J Am Acad Dermatol. 1983;8(5):686–96.
Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet. 2004; 41(5):323–6.
Guldberg P, Thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion of mutation is a frequent event in malignant melanoma. Cancer Res. 1997;57(17):3660–3.
Fistarol SK, Marc D, Anliker MS, Peter H. Cowden disease or multiple hamartoma syndrome—cutaneous clue to internal malignancy. Eur J Dermatol. 2002;12(5):411–21.
Brownstein MH, Mehregan AH, Bilowski JB. Trichilemmomas on Cowden’s disease. J Am Med Assoc. 1977;238(1):26.
Devlin MF, Barrie R, Ward-Booth RP. Cowden’s disease: a rare but important manifestation of oral papillomatosis. Br J Oral Maxillofacial Surg. 1992;30:335–6.
Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Human Genet. 2008;16:1289–300.
Nusbaum R, Vogel JK, Ready K. Susceptibility to breast cancer: hereditary syndromes and low penetrance genes. Breast Dus. 2007;27:21–50.
Schrager CA, Schneider D, Gruener AC. Clinical and pathological features of breast disease in Cowden’s syndrome: an under-recognized syndrome with an increased risk of breast cancer. Human Pathol. 1998;29:47–53.
Brownstein MH, Wolf M, Bikowski JB. Cowden’s disease: a cutaneous marker of breast cancer. Cancer. 1978;41:2393–8.
Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev. 2010;8: 577–83.
Pilariski R. Cowden syndrome: a critical review. J Genet Counsel. 2009;18:13–27.
Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, et al. Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine. 2005;84(2):129–36. doi:10.1097/01.md.0000158792.24888.d2.
Bagan JV, Penarrocha M, Vera-Sempere F. Cowden syndrome: clinical and pathological considerations in two new cases. J Oral Maxillofacial Surg. 1989;47(3):291–4. doi:10.1016/ 0278-2391(89)90234-6.
Starink TM. Cowden’s disease: analysis of fourteen new cases. J Am Acad Dermatol. 1984;11(6):1127–41. doi:10.1016/S0190-9622(84)70270-2.
Salem OS, Steck WD (1983) Cowden’s disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol. 8(5):686–96.aa
Parisi M, Dinulos MB, Leppid KA, Sybert VP, Eng C, Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet. 2001;38:52–7.
The NCCN 1.2009 Cowden syndrome clinical practice guidelines in oncology. National Comprehensive Cancer Network, 2009. Available from: http://www.nccn.org. Adapted with permission from NCCN [accessed 10.06.09]. (To view the most recent and complete version of the guideline, go online to www.nccn.org).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Linkner, R.V., Zeichner, J.A. (2014). Cowden Syndrome. In: Zeichner, J. (eds) Acneiform Eruptions in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8344-1_28
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8344-1_28
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8343-4
Online ISBN: 978-1-4614-8344-1
eBook Packages: MedicineMedicine (R0)